Aquaculture for all

GM Salmon Announced "Safe"

Salmonids Breeding & genetics +1 more

US - The Veterinary Medical Advisory Committee (VMAC) of the Food and Drug Administration (FDA) has published its interim reports, which note that the FDA has essentially found the AquAdvantage genetically modified (GM) salmon to be equivalent to other non-transgenic salmon.

This is another milestone for AquaBounty Technologies towards its pending approval of its AquAdvantage salmon product from the FDA.

AquAdvantage Salmon is a genetically-engineered Atlantic salmon with a rapid-growth phenotype that has been developed over the past 15 years.

In an Environmental Assessment, the VMAC has said, that AquAdvantage salmon are highly unlikely to cause any significant effects on the environment, inclusive of the global commons, foreign nations and stocks of wild Atlantic salmon.

On 19-20 September, the VMAC will meet to discuss and vote on AquaBounty’s application.

Further Reading

- Go to our previous news item on this story by clicking here.
Create an account now to keep reading

It'll only take a second and we'll take you right back to what you were reading. The best part? It's free.

Already have an account? Sign in here